Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel +/- Infliximab for Wasting, Anorexia, and Asthenia in NSCLC
NCT00040885Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2002
- Primary completion
- Feb 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in cachexia, anorexia nervosa (AN), fatigue, sponsored by Cancer and Leukemia Group B. Started Oct 2002; status: completed.
02
Drugs
infliximab
03
Conditions
cachexiaanorexia nervosa (AN)fatigue
Beyond the preview
Go deeper on NCT00040885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040885.